Dashboard
Manage Tickers

AFMD Affimed N.V.

Nasdaq affimed.com


nm (nm)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 615.92 $ 0.00 (0 %)
DIA $ 469.48 $ 0.00 (0 %)
SPY $ 675.86 $ 0.00 (0 %)
TLT $ 91.59 $ 0.00 (0 %)
GLD $ 376.24 $ 0.00 (0 %)
$ na
-- x --
-- x --
-- - --
nm - nm
0
na
1,523
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dow-tumbles-200-points-zim-integrated-shipping-services-posts-upbeat-earnings
Dow Tumbles 200 Points; ZIM Integrated Shi...
05/19/2025 13:58:42

why-novavax-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket
Why Novavax Shares Are Trading Higher By A...
05/19/2025 10:34:22

us-stocks-edge-higher-consumer-sentiment-falls-in-may
US Stocks Edge Higher; Consumer Sentiment ...
05/16/2025 14:22:46

hc-wainwright--co-downgrades-affimed-to-neutral
HC Wainwright & Co. Downgrades Affimed to ...
05/14/2025 17:03:51

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Affimed (NASDAQ:AFMD) from Buy to Neutral.

affimed-receives-nasdaq-delisting-notice-trading-to-be-suspended-may-20
Affimed Receives Nasdaq Delisting Notice; ...
05/14/2025 10:47:11

Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to ...

wells-fargo-downgrades-affimed-to-equal-weight-lowers-price-target-to-01
Wells Fargo Downgrades Affimed to Equal-We...
05/13/2025 22:05:24

Wells Fargo analyst Yanan Zhu downgrades Affimed (NASDAQ:AFMD) from Overweight to Equal-Weight and lowers the price target f...

crude-oil-gains-3-us-inflation-eases-in-april
Crude Oil Gains 3%; US Inflation Eases In ...
05/13/2025 17:11:19

nasdaq-rises-over-1-under-armour-posts-strong-q4-sales
Nasdaq Rises Over 1%; Under Armour Posts S...
05/13/2025 14:33:26

trading-halt-halt-status-updated-at-85000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:50:...
05/13/2025 12:50:07

this-caterpillar-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday
This Caterpillar Analyst Turns Bullish; He...
05/13/2025 12:47:39

trading-halt-halted-at-82500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 8:25:00 a.m. ET - ...
05/13/2025 12:25:05

this-rapid7-analyst-turns-bearish-here-are-top-4-downgrades-for-tuesday
This Rapid7 Analyst Turns Bearish; Here Ar...
05/13/2025 12:00:43

Core News & Articles
Stanley Black & Decker To Rally Around 24%...
05/13/2025 11:53:23

leerink-partners-downgrades-affimed-to-market-perform-lowers-price-target-to-039
Leerink Partners Downgrades Affimed to Mar...
05/13/2025 10:54:23

Leerink Partners analyst Daina Graybosch downgrades Affimed (NASDAQ:AFMD) from Outperform to Market Perform and lowers the p...

affimed-demonstrates-increased-afm24-exposure-correlates-with-improved-response-rates-and-progression-free-survival-in-refractory-nsclc-patients-at-aacr-annual-meeting
Affimed Demonstrates Increased AFM24 Expos...
04/29/2025 14:06:39

affimed-says-abstract-on-phase-2-luminice-203-study-of-ice-acimtamig-in-combination-with-ab-101-accepted-for-oral-presentation-at-asco-2025
Affimed Says Abstract On Phase 2 LuminICE-...
04/23/2025 14:11:53

MANNHEIM, Germany, April 23, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD) ("Affimed", or the "Company"),...

affimed-receives-nasdaq-notice-over-low-share-price-has-until-october-to-regain-compliance
Affimed Receives Nasdaq Notice Over Low Sh...
04/21/2025 10:32:09

Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to ...

affimed-reports-results-for-cancer-therapy-in-nsclc-patients
Affimed Reports Results for Cancer Therapy...
12/17/2024 11:31:46

Affimed N.V. (NASDAQ:AFMD) ("Affimed," or the "Company"), a clinical-stage immuno-oncology company committed to...

wells-fargo-maintains-overweight-on-affimed-lowers-price-target-to-15
Wells Fargo Maintains Overweight on Affime...
12/12/2024 19:18:29

Wells Fargo analyst Yanan Zhu maintains Affimed (NASDAQ:AFMD) with a Overweight and lowers the price target from $20 to $15.

hc-wainwright--co-reiterates-buy-on-affimed-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Affi...
12/10/2024 12:24:51

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Affimed (NASDAQ:AFMD) with a Buy and maintains $10 price t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION